These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

521 related articles for article (PubMed ID: 23973912)

  • 1. Nanopreparations to overcome multidrug resistance in cancer.
    Patel NR; Pattni BS; Abouzeid AH; Torchilin VP
    Adv Drug Deliv Rev; 2013 Nov; 65(13-14):1748-62. PubMed ID: 23973912
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exploiting nanotechnology to overcome tumor drug resistance: Challenges and opportunities.
    Kirtane AR; Kalscheuer SM; Panyam J
    Adv Drug Deliv Rev; 2013 Nov; 65(13-14):1731-47. PubMed ID: 24036273
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multi-modal strategies for overcoming tumor drug resistance: hypoxia, the Warburg effect, stem cells, and multifunctional nanotechnology.
    Milane L; Ganesh S; Shah S; Duan ZF; Amiji M
    J Control Release; 2011 Oct; 155(2):237-47. PubMed ID: 21497176
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of integrated cancer nanomedicine in overcoming drug resistance.
    Iyer AK; Singh A; Ganta S; Amiji MM
    Adv Drug Deliv Rev; 2013 Nov; 65(13-14):1784-802. PubMed ID: 23880506
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reversion of multidrug resistance in tumor by biocompatible nanomaterials.
    Zhang H; Jiang H; Wang X; Chen B
    Mini Rev Med Chem; 2010 Jul; 10(8):737-45. PubMed ID: 20565385
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overcoming multidrug resistance in cancer: Recent progress in nanotechnology and new horizons.
    Majidinia M; Mirza-Aghazadeh-Attari M; Rahimi M; Mihanfar A; Karimian A; Safa A; Yousefi B
    IUBMB Life; 2020 May; 72(5):855-871. PubMed ID: 31913572
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cancer multidrug resistance: mechanisms involved and strategies for circumvention using a drug delivery system.
    Kibria G; Hatakeyama H; Harashima H
    Arch Pharm Res; 2014 Jan; 37(1):4-15. PubMed ID: 24272889
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multidrug resistance: Physiological principles and nanomedical solutions.
    Kunjachan S; Rychlik B; Storm G; Kiessling F; Lammers T
    Adv Drug Deliv Rev; 2013 Nov; 65(13-14):1852-1865. PubMed ID: 24120954
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeted nanomedicine for cancer therapeutics: Towards precision medicine overcoming drug resistance.
    Bar-Zeev M; Livney YD; Assaraf YG
    Drug Resist Updat; 2017 Mar; 31():15-30. PubMed ID: 28867241
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overcoming drug efflux-based multidrug resistance in cancer with nanotechnology.
    Xue X; Liang XJ
    Chin J Cancer; 2012 Feb; 31(2):100-9. PubMed ID: 22237039
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reversal of multidrug resistance by stimuli-responsive drug delivery systems for therapy of tumor.
    Yin Q; Shen J; Zhang Z; Yu H; Li Y
    Adv Drug Deliv Rev; 2013 Nov; 65(13-14):1699-715. PubMed ID: 23611952
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent progress in nanotechnology for cancer therapy.
    Tang MF; Lei L; Guo SR; Huang WL
    Chin J Cancer; 2010 Sep; 29(9):775-80. PubMed ID: 20800018
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
    Pérez-Herrero E; Fernández-Medarde A
    Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Emerging nanotechnology-based therapeutics to combat multidrug-resistant cancer.
    Yadav P; Ambudkar SV; Rajendra Prasad N
    J Nanobiotechnology; 2022 Sep; 20(1):423. PubMed ID: 36153528
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nanomaterial-induced autophagy: a new reversal MDR tool in cancer therapy?
    Panzarini E; Dini L
    Mol Pharm; 2014 Aug; 11(8):2527-38. PubMed ID: 24921216
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nanotechnology applied to overcome tumor drug resistance.
    Gao Z; Zhang L; Sun Y
    J Control Release; 2012 Aug; 162(1):45-55. PubMed ID: 22698943
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nanoparticle approaches to combating drug resistance.
    Moon JH; Moxley JW; Zhang P; Cui H
    Future Med Chem; 2015 Aug; 7(12):1503-10. PubMed ID: 26334205
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improvement of conventional anti-cancer drugs as new tools against multidrug resistant tumors.
    Dallavalle S; Dobričić V; Lazzarato L; Gazzano E; Machuqueiro M; Pajeva I; Tsakovska I; Zidar N; Fruttero R
    Drug Resist Updat; 2020 May; 50():100682. PubMed ID: 32087558
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeted cancer therapy; nanotechnology approaches for overcoming drug resistance.
    Gao Y; Shen JK; Milane L; Hornicek FJ; Amiji MM; Duan Z
    Curr Med Chem; 2015; 22(11):1335-47. PubMed ID: 25666804
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nanoparticles in Cancer Treatment: Opportunities and Obstacles.
    Awasthi R; Roseblade A; Hansbro PM; Rathbone MJ; Dua K; Bebawy M
    Curr Drug Targets; 2018; 19(14):1696-1709. PubMed ID: 29577855
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.